BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease is a research paper published in Neurotherapeutics (2020). On theSindex it has a DataRank of 0.449. It has been cited 19 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.449
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Neurological Disorders and Stroke
Grant: NS095656
NINDS NIH HHS
Grant: R21 NS095656
National Institutes of Health
Grant: 1R21NS095656-01A1
BDNF rs6265 and Response to Dopaminergic Therapy in PD
Saint Mary’s Foundation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals